SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences.
HIGHLIGHTS Safety Review Committee (SRC) meeting confirms end of the Dose Escalation Phase and commencement of the Cohort Expansion Phase (Phase II stage) of the SECuRE study. Based on the efficacy and safety assessment of all cohorts and the focus...
MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial, recommending continued progression as planned MRX-4 Injection followed by Contezolid Tablets demonstrated favorable safety...
HKBU scientist's Automated Multiplex Diagnostics System recommended by WHO as an innovative health technology for low-resource contexts
HONG KONG, Dec. 3, 2024 /PRNewswire/ -- The Automated Multiplex Diagnostics System developed by Professor Terence Lau, Interim Chief Innovation Officer of Hong Kong Baptist University (HKBU), has been recommended in the 2024 Compendium of Innovative...